首页> 美国卫生研究院文献>Oxford Open >252. Development and Evaluation of a Novel MultiCode Real-Time PCR Assay for the Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid and Induced Sputum
【2h】

252. Development and Evaluation of a Novel MultiCode Real-Time PCR Assay for the Detection of Pneumocystis jirovecii in Bronchoalveolar Lavage Fluid and Induced Sputum

机译:252.新型多码实时PCR检测试剂盒的检测和评估用于检测支气管肺泡灌洗液和诱导痰中的纳氏肺孢子虫

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background Pneumocystis jirovecii is a medically important fungal pathogen responsible for opportunistic infections in immunocompromised hosts with high morbidity and mortality. Compared with standard microscopy based assays, home-brew nucleic acid amplification tests (NAAT) have emerged as sensitive tools for the diagnosis of P. jirovecii pneumonia, but their sensitivities vary depending upon selected genetic targets. Recent studies suggest that the mitochondrial small subunit (mtSSU) is a better NAAT target given its higher copy number and stable expression in the disease process. We aimed to develop and evaluate a mtSSU-targeted MultiCode real-time PCR assay that incorporates a sample processing control (SPC) and enables detection of P. jirovecii in bronchoalveolar lavage fluid (BALF) and induced sputum.
机译:背景技术吉罗韦氏肺孢子虫是一种医学上重要的真菌病原体,负责免疫受损的宿主中的机会性感染,发病率和死亡率很高。与基于标准显微镜的检测方法相比,自酿核酸扩增检测法(NAAT)已成为诊断jirovecii肺炎的敏感工具,但其敏感性取决于所选的遗传靶点。最近的研究表明,线粒体小亚基(mtSSU)是更好的NAAT靶标,因为它在疾病过程中具有更高的拷贝数和稳定的表达。我们旨在开发和评估以mtSSU为目标的MultiCode实时PCR分析方法,该方法结合了样品处理控制(SPC),并能够检测支气管肺泡灌洗液(BALF)和诱导痰中的jirovecii。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号